Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Comorbidities Reduce Response to Induction Treatment and Survival in Adults with Philadelphia-Negative Acute Lymphoblastic Leukemia

Ilaria Tanasi, Veronica Tagliaferri, Cristina Tecchio, Fiorenza Aprili, Giovanna De Matteis, Giovanni Pizzolo, Mauro Krampera, Massimiliano Bonifacio, MD

Blood (2019) 134 (Supplement_1): 2587.

https://doi.org/10.1182/blood-2019-130160

Published: 2019

Journal Articles

Importance of Detection of Intracellular Myeloperoxidase, CD13, CD79a, CD22, CD3 and Terminal Deoxynucleotidyl Transferase By Flow Cytometry Diagnosis of Acute Leukemias

Aldair Sousa Paiva, PhD, Hugo Diogenes De Oliveira Paiva, MD, Geraldo Barroso Cavalcanti, Jr., PhD, Frank Bahia, MD, Rodrigo Villar Freitas, MD, Lenilton Silva Silveira, Jr., MD, Lorena KF Silva, Roberto C Vasconcelos, MD, Dany GKC Silva, Victor lima Soares, Erica Aires Gil, MD, Geisa Januario, Maria Fernandes, PhD, Alessandra Suelen Jardim

Blood (2018) 132 (Supplement 1): 5194.

https://doi.org/10.1182/blood-2018-99-118880

Published: 2018

Journal Articles

Mice with a Unique Mutator Phenotype Allow Detection of Lymphoid Leukemia Tumor Suppressor Genes

Mianmian Yin, PhD, Timour Baslan, PhD, Amy Freeland, PhD, Toshihiro Matsukawa, PhD, Steven C. Pruitt, PhD, Peter D. Aplan, MD

Blood (2018) 132 (Supplement 1): 1332.

https://doi.org/10.1182/blood-2018-99-115176

Published: 2018

Journal Articles

Risk of Central Nervous System Relapse in Patient with Peripheral T-Cell Lymphoma: Absolute Lymphocytes Count and Lymphocytes Percent at Diagnosis As Predictors

Tariq Zuheir Kewan, MD, Mahmoud Husni Hajyousef, MD, Associate Professor, Deeb Jamil Zahran, MD, Sohaib Mahmoud Al-Khatib, MD

Blood (2017) 130 (Supplement 1): 5185.

https://doi.org/10.1182/blood.V130.Suppl_1.5185.5185

Published: 2017

Journal Articles

Inhibition of WHSC1 As a Promising Therapeutic Strategy in Childhood ALL

Haytham Khoury, MD PhD, Noël Raynal, PhD, Pascal St-Onge, Maxime Caron, Annie Beaudry, Daniel Sinnett, PhD

Blood (2017) 130 (Supplement 1): 2072.

https://doi.org/10.1182/blood.V130.Suppl_1.2072.2072

Published: 2017

Journal Articles

Safety and Efficacy of Enoxaparin Prophylaxis in Adults Receiving Peg-Asparaginase Containing Induction Regimens for Acute Lymphoblastic Leukemia (ALL)

Jayadev Manikkam Umakanthan, MBBS, Lori J. Maness, MD, Jiangtao Luo, Avyakta Kallam, MBBS, James O. Armitage, MD, Philip Bierman, MD, Julie M. Vose, MD, R. Gregory Bociek, MD, Matthew Lunning, DO, Krishna Gundabolu, MD, Vijaya R. Bhatt, MD

Blood (2016) 128 (22): 5154.

https://doi.org/10.1182/blood.V128.22.5154.5154

Published: 2016

Journal Articles

Persistence of Cytogenetic Abnormalities at Complete Remission Is Not Prognostic for Relapse-Free or Overall Survival in Adult Patients with Acute Lymphoblastic Leukemia

Nicholas J. Short, MD, Hagop M. Kantarjian, MD, Elias Jabbour, Susan O'Brien, MD, Stefan Faderl, MD, Jan A. Burger, MD PhD, Rebecca Garris, Wei Qiao, Xuelin Huang, PhD, Nitin Jain, MD, Marina Konopleva, MD PhD, Tapan Kadia, MD, Naval Daver, MD, Gautam Borthakur, MD, Jorge E. Cortes, Farhad Ravandi, MD

Blood (2015) 126 (23): 1416.

https://doi.org/10.1182/blood.V126.23.1416.1416

Published: 2015

Journal Articles

The Clinical Features and Prognosis of Early T-Cell Precursor Subtype of Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study

Reiji Fukano, MD PhD, Shosuke Sunami, MD PhD, Masahiro Sekimizu, MDPhD, Tetsuya Takimoto, Tetsuya Mori, MDPhD, Tetsuo Mitsui, MD PhD, Takeshi Mori, MD, PhD, Akiko Moriya Saito, MD PhD, Tomoyuki Watanabe, Koichi Ohshima, Junichiro Fujimoto, MD PhD, Atsuko Nakazawa, MD PhD, Nobutaka Kiyokawa, MD PhD, Ryoji Kobayashi, MD PhD, Keizo Horibe, MD PhD, Masahito Tsurusawa, MD PhD

Blood (2014) 124 (21): 1728.

https://doi.org/10.1182/blood.V124.21.1728.1728

Published: 2014

Journal Articles

Illegitimate V(D)J Recombination Involving Notch1 and Bcl11b in Precursor T-Cell Lymphoblastic Leukemia/Lymphoma

Masahiro Onozawa, MD, PhD., Hyunkyung Kim, MD, PhD., Sheryl M Gough, BSc, PhD, Yingwei Lin, MD., PhD., Yongzhi Cui, MD, PhD., Sarah H Beachy, PhD, Crystal L Mackall, MD, Peter Aplan, MD

Blood (2012) 120 (21): 1323.

https://doi.org/10.1182/blood.V120.21.1323.1323

Published: 2012

Journal Articles

A Dual Proto-Oncogenic and Tumor Suppressive Role of LRF/POKEMON In Hemopoietic Malignancies through Control of Cell Fate Decision

Pier Paolo Pandolfi, MD, PhD

Blood (2010) 116 (21): SCI-14.

https://doi.org/10.1182/blood.V116.21.SCI-14.SCI-14

Published: 2010

Journal Articles

Dual Inhibition of mTOR and Pim Kinase Pathways Using Small Molecule Inhibitors Synergistically Kills Myeloid Leukemic Cells In Vitro and In Vivo.

Yingwei Lin, MD., PhD., Amanda M Graham, MS., Luciano J Costa, MD., PhD., Zanna M Beharry, PhD., Michael S Rosol, PhD., Zuping Xia, PhD., Baby Tholanikunnel, PhD, Robert K Stuart, MD., Andrew S Kraft, MD

Blood (2010) 116 (21): 293.

https://doi.org/10.1182/blood.V116.21.293.293

Published: 2010

Journal Articles

VPREB1 Deletions Occur Independent of Lambda-Light Chain Rearrangement and Predict Worse Outcome In Pediatric Acute Lymphoblastic Leukemia (ALL)

Rodney R. Miles, MD, PhD, Jonathan Downie, BS, Mona S. Jahromi, BS, Deepa Joshi, BS, Vladimir Rodic, BS, Markus Muschen, MD, Jun J. Yang, PhD, William E. Evans, PharmD, Nathan Meeker, MD, Nikolaus Trede, MD, PhD, J. Kimble Frazer, MD, PhD, Phillip Barnette, MD, Joshua D. Schiffman, MD

Blood (2010) 116 (21): 273.

https://doi.org/10.1182/blood.V116.21.273.273

Published: 2010

Journal Articles

Augmented Hyper-CVAD in Adult ALL Salvage Therapy: The MDACC Experience of Hyper-CVAD Using Dose-Intense Vincristine, Dexamethasone, and Pegaspargase.

Mohamad Ayoubi, MD, Deborah A. Thomas, MD, Hagop Kantarjian, MD, Susan O'Brien, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Srdan Verstovsek, MD, Michael Rytting, MD, Gautam Borthakur, MD, Tapan Kadia, MD, Steven M. Kornblau, MD, Michael Andreeff, MD, PhD, Jenny Feliu, RN, Stefan Faderl, MD

Blood (2009) 114 (22): 2031.

https://doi.org/10.1182/blood.V114.22.2031.2031

Published: 2009

Journal Articles

AF4-MLL Expression Is Necessary and Sufficient for Leukemia Onset in Mice

Adelheid Bursen, PhD, Karen Schwabe, Brigitte Rüster, PhD, Anne Wenger, PhD, Martin Ruthardt, MD, Reinhard Henschler, MD, Theo Dingermann, PhD, Rolf Marschalek, PhD

Blood (2008) 112 (11): 685.

https://doi.org/10.1182/blood.V112.11.685.685

Published: 2008

Journal Articles

8p11–12 Myeloprolferative Syndrome: A Case Report and Brief Review of the Literature

Sarvari Venkata Yellapragada, MD, Martha P. Mims, MD, PhD, Courtney Jackson, MD, Mark Lewis, MD, Mark M. Udden, MD

Blood (2008) 112 (11): 5260.

https://doi.org/10.1182/blood.V112.11.5260.5260

Published: 2008

Journal Articles

Quantitative Measurement of CD52 Expression and Alemtuzumab Binding in Adult Acute Lymphoblastic Leukemia (ALL): Correlation with Immunophenotype and Cytogenetics in Patients (Pts) Enrolled on a Phase I/II Trial from the Cancer and Leukemia Group B (CALGB 10102).

Gerard Lozanski, MD, Ben Sanford, MS, Krzysztof Mrozek, MD, PhD, Colin Edwards, PhD, Rebecca Pearson, BS, Clara D. Bloomfield, MD, Richard A. Larson, MD, Wendy Stock, MD

Blood (2007) 110 (11): 2386.

https://doi.org/10.1182/blood.V110.11.2386.2386

Published: 2007

Journal Articles

Molecular Inversion Probes (MIPs) Identify Novel Areas of Allelic Imbalance in Childhood Leukemia.

Joshua D. Schiffman, MD, Katrina Welch, Ronald Davis, PhD, Norman J. Lacayo, MD, Gary V. Dahl, MD, Yuker Wang, PhD, Malek Faham, MD, James M. Ford, MD, Hanlee P. Ji, MD

Blood (2007) 110 (11): 1438.

https://doi.org/10.1182/blood.V110.11.1438.1438

Published: 2007

Journal Articles

CD52 Expression in Adult Acute Lymphoblastic Leukemia (ALL): Quantitative Flow Cytometry Provides New Insights.

Gerard Lozanski, MD, Ben Sanford, MS, Daohai Yu, PhD, Rebecca Pearson, MLT, Colin Edwards, MS, John C. Byrd, MD, Richard A. Larson, MD, Clara D. Bloomfield, MD, Wendy Stock, MD

Blood (2006) 108 (11): 2293.

https://doi.org/10.1182/blood.V108.11.2293.2293

Published: 2006

Journal Articles

Acquired Notch1 Mutations in Murine Precursor-T Leukemia/Lymphoma Models.

Yingwei Lin, MD, PhD, Rebecca A. Nichols, John J. Letterio, MD, Peter D. Aplan, MD

Blood (2005) 106 (11): 2612.

https://doi.org/10.1182/blood.V106.11.2612.2612

Published: 2005

Journal Articles

Evaluation of CD52 Expression in Hematopoietic Neoplasms by Standard Immunohistochemistry: Implications for the Expanded Use of Alemtuzumab (CAMPATH-1H) in the Treatment of Hematological Malignancies.

Scott J. Rodig, MD, PhD, Jeremy S. Abramson, MD, Geraldine S. Pinkus, MD, Steven P. Treon, MD, PhD, Margaret A. Shipp, MD, Jeffery L. Kutok, MD, PhD

Blood (2005) 106 (11): 3346.

https://doi.org/10.1182/blood.V106.11.3346.3346

Published: 2005

NARROW

Comorbidities Reduce Response to Induction Treatment and Survival in Adults with Philadelphia-Negative Acute Lymphoblastic Leukemia

Importance of Detection of Intracellular Myeloperoxidase, CD13, CD79a, CD22, CD3 and Terminal Deoxynucleotidyl Transferase By Flow Cytometry Diagnosis of Acute Leukemias

Mice with a Unique Mutator Phenotype Allow Detection of Lymphoid Leukemia Tumor Suppressor Genes

Risk of Central Nervous System Relapse in Patient with Peripheral T-Cell Lymphoma: Absolute Lymphocytes Count and Lymphocytes Percent at Diagnosis As Predictors

Inhibition of WHSC1 As a Promising Therapeutic Strategy in Childhood ALL

Safety and Efficacy of Enoxaparin Prophylaxis in Adults Receiving Peg-Asparaginase Containing Induction Regimens for Acute Lymphoblastic Leukemia (ALL)

Persistence of Cytogenetic Abnormalities at Complete Remission Is Not Prognostic for Relapse-Free or Overall Survival in Adult Patients with Acute Lymphoblastic Leukemia

The Clinical Features and Prognosis of Early T-Cell Precursor Subtype of Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study

Illegitimate V(D)J Recombination Involving Notch1 and Bcl11b in Precursor T-Cell Lymphoblastic Leukemia/Lymphoma

A Dual Proto-Oncogenic and Tumor Suppressive Role of LRF/POKEMON In Hemopoietic Malignancies through Control of Cell Fate Decision

Dual Inhibition of mTOR and Pim Kinase Pathways Using Small Molecule Inhibitors Synergistically Kills Myeloid Leukemic Cells In Vitro and In Vivo.

VPREB1 Deletions Occur Independent of Lambda-Light Chain Rearrangement and Predict Worse Outcome In Pediatric Acute Lymphoblastic Leukemia (ALL)

Augmented Hyper-CVAD in Adult ALL Salvage Therapy: The MDACC Experience of Hyper-CVAD Using Dose-Intense Vincristine, Dexamethasone, and Pegaspargase.

AF4-MLL Expression Is Necessary and Sufficient for Leukemia Onset in Mice

8p11–12 Myeloprolferative Syndrome: A Case Report and Brief Review of the Literature

Quantitative Measurement of CD52 Expression and Alemtuzumab Binding in Adult Acute Lymphoblastic Leukemia (ALL): Correlation with Immunophenotype and Cytogenetics in Patients (Pts) Enrolled on a Phase I/II Trial from the Cancer and Leukemia Group B (CALGB 10102).

Molecular Inversion Probes (MIPs) Identify Novel Areas of Allelic Imbalance in Childhood Leukemia.

CD52 Expression in Adult Acute Lymphoblastic Leukemia (ALL): Quantitative Flow Cytometry Provides New Insights.

Acquired Notch1 Mutations in Murine Precursor-T Leukemia/Lymphoma Models.

Evaluation of CD52 Expression in Hematopoietic Neoplasms by Standard Immunohistochemistry: Implications for the Expanded Use of Alemtuzumab (CAMPATH-1H) in the Treatment of Hematological Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only